Analog of Kynurenic Acid Decreases Tau Pathology by Modulating Astrogliosis in Rat Model for Tauopathy.
Petra Majerová, Dominika Olešová, Greta Golisova, Martina Buralova, Alena Michalicová, Jozef Vegh, Juraj Piešťanský, Mangesh Ramesh Bhide, Jozef Hanes, Andrej Kováč
This study shows that chronic administration of KYNA-1, a kynurenic acid analog, reduces tau hyperphosphorylation and neuroinflammation in a tau transgenic rat model.
Biomedicine & Pharmacotherapy · Jun 13, 2022Peer-reviewedNeuroscience